Also known as: Pepaxto

Melflufen was an FDA-approved peptide-drug conjugate for a blood cancer called multiple myeloma.

📖 Read the full Melflufen research overview →

Evidence Tier: Tier 2 — Clinical Trials · Peptidings Verdict: Thin Ice